Related Experiment Video
Updated: May 19, 2026

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
Published on: December 21, 2019
Thumb inhibitor binding eliminates functionally important dynamics in the hepatitis C virus RNA polymerase
Brittny C Davis1, Ian F Thorpe
1Department of Chemistry and Biochemistry, University of Maryland-Baltimore County, Baltimore, Maryland 21250, USA.
Allosteric inhibitors targeting Hepatitis C virus RNA polymerase (NS5B) alter enzyme structure and motion, blocking RNA replication. This study reveals a mechanistic basis for allosteric inhibition, crucial for developing new antiviral therapies.
Area of Science:
- Virology
- Biochemistry
- Drug Discovery
Background:
- Hepatitis C virus (HCV) affects millions globally, causing chronic liver damage.
- Limited treatments exist for HCV infection, necessitating novel therapeutic strategies.
- HCV RNA-dependent RNA polymerase (NS5B) is a key target for antiviral drug development.
Purpose of the Study:
- To elucidate the molecular mechanism of long-range allosteric inhibition of HCV NS5B.
- To investigate how allosteric inhibitors binding to the thumb domain affect enzyme dynamics and function.
Main Methods:
- Molecular dynamics simulations of HCV NS5B with and without an allosteric inhibitor.
- Principal components analysis to identify key enzyme motions affected by inhibitor binding.
Main Results:
- Inhibitor binding to the NS5B thumb domain alters enzyme structure and internal motions.
- Specific motions crucial for RNA replication are attenuated by inhibitor presence.
- Inhibitor binding leads to narrower RNA binding channels, hindering template/nascent RNA interactions.
Conclusions:
- This study provides the first mechanistic evidence for allosteric inhibition of HCV NS5B.
- Allosteric inhibition arises from intrinsic features of the enzyme's free energy landscape.
- A common mechanism for diverse allosteric ligands targeting NS5B is suggested.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Hepatitis
Enzyme Inhibition
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Viruses with RNA Genomes
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...

